Immune checkpoint inhibitors (ICIs) are increasingly used across disease stages, including adjuvant, first-line metastatic, and later-line settings, leading to a growing population of women of reproductive age exposed to these agents. As survival improves, rep... ...

请注册登录后继续浏览